Genocea Biosciences, Inc. (GNCA) Social Stream
GENOCEA BIOSCIENCES INC (GNCA) Price Targets From Analysts
Use the tables below to see what analysts covering GENOCEA BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-10-28 | 3 | $9 | $4.5 | $6.375 | $0.062 | 10182.26% |
2022-03-10 | 3 | $9 | $4.5 | $6.5 | $0.062 | 10383.87% |
2022-04-11 | 3 | $9 | $4.7 | $6.566 | $0.062 | 10490.32% |
2022-04-12 | 3 | $9 | $3 | $5.675 | $0.062 | 9053.23% |
2022-04-27 | 3 | $9 | $3 | $5.425 | $0.062 | 8650% |
2022-04-28 | 2 | $3 | $0.16 | $1.58 | $0.062 | 2448.39% |
The Trend in the Analyst Price Target
Over the past 25 months, GNCA's average price target has gone down $13.28.
GNCA reports an average of 368.46% for its upside potential over the past 47 weeks.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2021-08-05 | 3 | 8 | 4.40 | 6.100 | 2.000 | 205% |
2022-04-11 | 3 | 9 | 4.70 | 6.566 | 0.600 | 994.33% |
2022-04-12 | 3 | 9 | 3.00 | 5.675 | 0.490 | 1058.16% |
2022-04-27 | 3 | 9 | 3.00 | 5.425 | 0.410 | 1223.17% |
2022-04-28 | 3 | 5 | 0.16 | 2.720 | 0.408 | 566.67% |
GNCA Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
3 | 0 | 0 | 2 | 0 | 0 | 2 |
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- GENOCEA BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 699.53% of all US stocks.
- GENOCEA BIOSCIENCES INC's average analyst price target is greater than 22.68% of all US stocks.
- In the context of Healthcare stocks, GENOCEA BIOSCIENCES INC's number of analysts covering the stock is higher than 74.83% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, GENOCEA BIOSCIENCES INC's variance in analysts' estimates is lower than -504.93% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to GENOCEA BIOSCIENCES INC are GMDA, GLUE, and FUSN.
View All Top Stocks by Price Target
Is GNCA a Buy, Hold or Sell? See the POWR Ratings now!